BSX vs MG · P/E 20, rev $16.75B vs P/E 18, rev $729.6M
Boston Scientific Corp (BSX) versus Mistras Group Inc (MG) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Mistras Group Inc (MG) is a security & protection services company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MG revenue for 2024-12-31 was $729.6M. Net income was $19.0M. Revenue was up 300.7% from 2023-12-31 to 2024-12-31. MG currently screens at market cap $258.5M and trailing P/E 17.7.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MG currently screens at market cap $258.5M and trailing P/E 17.7.
Not investment advice. Open the BSX and MG stock pages for the full models.
Not investment advice.